122 related articles for article (PubMed ID: 6321113)
1. Lung involvement in scleroderma.
König G; Luderschmidt C; Hammer C; Adelmann-Grill BC; Braun-Falco O; Fruhmann G
Chest; 1984 Mar; 85(3):318-24. PubMed ID: 6321113
[TBL] [Abstract][Full Text] [Related]
2. [New knowledge on the diagnosis and prognosis of interstitial lung disease in scleroderma].
König G; Behr J; Luderschmidt C
Z Rheumatol; 1990; 49(5):279-83. PubMed ID: 2080684
[TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage analysis of interstitial lung disease in CREST syndrome.
Pesci A; Bertorelli G; Manganelli P; Ambanelli U
Clin Exp Rheumatol; 1986; 4(2):121-4. PubMed ID: 3731570
[TBL] [Abstract][Full Text] [Related]
4. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function.
Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C
Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625
[TBL] [Abstract][Full Text] [Related]
5. Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features.
Edelson JD; Hyland RH; Ramsden M; Chamberlain DW; Kortan P; Meindok HO; Klein MH; Braude AC; Lee P; Rebuck AS
J Rheumatol; 1985 Oct; 12(5):957-63. PubMed ID: 4087272
[TBL] [Abstract][Full Text] [Related]
6. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.
Silver RM; Metcalf JF; Stanley JH; LeRoy EC
Arthritis Rheum; 1984 Nov; 27(11):1254-62. PubMed ID: 6497920
[TBL] [Abstract][Full Text] [Related]
7. Persistence of abnormal bronchoalveolar lavage findings after cyclophosphamide treatment in scleroderma patients with interstitial lung disease.
Mittoo S; Wigley FM; Wise R; Xiao H; Hummers L
Arthritis Rheum; 2007 Dec; 56(12):4195-202. PubMed ID: 18050251
[TBL] [Abstract][Full Text] [Related]
8. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.
Rossi GA; Bitterman PB; Rennard SI; Ferrans VJ; Crystal RG
Am Rev Respir Dis; 1985 Apr; 131(4):612-7. PubMed ID: 3994157
[TBL] [Abstract][Full Text] [Related]
9. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung.
Behr J; Vogelmeier C; Beinert T; Meurer M; Krombach F; König G; Fruhmann G
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):400-6. PubMed ID: 8756813
[TBL] [Abstract][Full Text] [Related]
10. [Clinical value of bronchoalveolar lavage in progressive systemic scleroderma (author's transl)].
König G; Luderschmidt C; Clocuh YP; Scherer U; Fruhmann G
Dtsch Med Wochenschr; 1982 May; 107(19):723-7. PubMed ID: 7075490
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary function in progressive systemic sclerosis. Comparison of CREST syndrome variant with diffuse scleroderma.
Owens GR; Fino GJ; Herbert DL; Steen VD; Medsger TA; Pennock BE; Cottrell JJ; Rodnan GP; Rogers RM
Chest; 1983 Nov; 84(5):546-50. PubMed ID: 6628005
[TBL] [Abstract][Full Text] [Related]
12. Adult bronchiolitis. Evaluation by bronchoalveolar lavage and response to prednisone therapy.
Dorinsky PM; Davis WB; Lucas JG; Weiland JE; Gadek JE
Chest; 1985 Jul; 88(1):58-63. PubMed ID: 4006557
[TBL] [Abstract][Full Text] [Related]
13. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
Owens GR; Paradis IL; Gryzan S; Medsger TA; Follansbee WP; Klein HA; Dauber JH
J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary manifestations of systemic scleroderma: pathophysiologic and clinical significance of the activation of lung fibroblasts].
Behr J; Adelmann-Grill BC; Hein R; Schwaiblmair M; Degenkolb B; Krombach F; Fruhmann G
Pneumologie; 1995 Apr; 49(4):266-72. PubMed ID: 7792285
[TBL] [Abstract][Full Text] [Related]
15. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary cell populations in the immunosuppressed patient. Bronchoalveolar lavage findings during episodes of pneumonitis.
White DA; Gellene RA; Gupta S; Cunningham-Rundles C; Stover DE
Chest; 1985 Sep; 88(3):352-9. PubMed ID: 4028844
[TBL] [Abstract][Full Text] [Related]
17. Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid.
Silver RM; Metcalf JF; LeRoy EC
Arthritis Rheum; 1986 Apr; 29(4):525-31. PubMed ID: 3707630
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of eosinophils in pulmonary fibrosis.
Peterson MW; Monick M; Hunninghake GW
Chest; 1987 Jul; 92(1):51-6. PubMed ID: 3595249
[TBL] [Abstract][Full Text] [Related]
19. Bronchoalveolar lavage--a sensitive tool for early diagnosis of pulmonary involvement in rheumatoid arthritis.
Tishler M; Grief J; Fireman E; Yaron M; Topilsky M
J Rheumatol; 1986 Jun; 13(3):547-50. PubMed ID: 3735275
[TBL] [Abstract][Full Text] [Related]
20. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
